Yalcin S - Search Results

1

Emerging treatment strategies in hepatobiliary cancer.

Guven DC, Yildirim HC, Chalabiyev E, Kus F, Yilmaz F, Yasar S, Akyildiz A, Aktas BY, Yalcin S, Dizdar O. Guven DC, et al. Among authors: yalcin s. Expert Rev Anticancer Ther. 2023 Mar;23(3):243-256. doi: 10.1080/14737140.2023.2183844. Epub 2023 Mar 1. Expert Rev Anticancer Ther. 2023. PMID: 36803258 Review.

2

Nilotinib is effective in imatinib and sunitinib resistant GIST: a case report.

Dizdar O, Yalcin S. Dizdar O, et al. Among authors: yalcin s. Hepatogastroenterology. 2011 May-Jun;58(107-108):859-60. Hepatogastroenterology. 2011. PMID: 21830404

3

Nilotinib in advanced gastrointestinal stromal tumors after imatinib and sunitinib therapy.

Dizdar O, Yalcin S. Dizdar O, et al. Among authors: yalcin s. Hepatogastroenterology. 2011 Nov-Dec;58(112):2012-4. doi: 10.5754/hge11274. Hepatogastroenterology. 2011. PMID: 22024073

4

Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy.

Ozcan MF, Dizdar O, Dincer N, Balcı S, Guler G, Gok B, Pektas G, Seker MM, Aksoy S, Arslan C, Yalcin S, Balbay MD. Ozcan MF, et al. Among authors: yalcin s. Urol Oncol. 2013 Nov;31(8):1709-15. doi: 10.1016/j.urolonc.2012.06.014. Epub 2012 Aug 3. Urol Oncol. 2013. PMID: 22863869

5

Renal cell cancer: overview of the current therapeutic landscape.

Erman M, Benekli M, Basaran M, Bavbek S, Buyukberber S, Coskun U, Demir G, Karabulut B, Oksuzoglu B, Ozkan M, Sevinc A, Yalcin S. Erman M, et al. Among authors: yalcin s. Expert Rev Anticancer Ther. 2016 Sep;16(9):955-68. doi: 10.1080/14737140.2016.1222908. Epub 2016 Aug 24. Expert Rev Anticancer Ther. 2016. PMID: 27548347 Review.

6

Recent advances in the management of pancreatic adenocarcinoma.

Karakas Y, Lacin S, Yalcin S. Karakas Y, et al. Among authors: yalcin s. Expert Rev Anticancer Ther. 2018 Jan;18(1):51-62. doi: 10.1080/14737140.2018.1403319. Epub 2017 Nov 13. Expert Rev Anticancer Ther. 2018. PMID: 29125367 Review.

7

Real world survival data of a rare malignancy: Anal cancer results in HIV negative patients from Turkey.

Esin E, Yıldız F, Laçin Ş, Karakaş Y, Gültekin M, Dizdar Ö, Yalçın Ş. Esin E, et al. Among authors: yalcin s. Turk J Gastroenterol. 2018 Jul;29(4):411-418. doi: 10.5152/tjg.2018.17660. Turk J Gastroenterol. 2018. PMID: 30249555 Free PMC article.

8

The frequency and predictors of persistent amenorrhea in premenopausal women with colorectal cancer who received adjuvant chemotherapy.

Sahin T, Dizdar O, Ozdemir N, Zengin N, Ates O, Oksuzoglu B, Sendur MAN, Bilgin B, Demir M, Bozbulut UB, Kilickap S, Yalcin S. Sahin T, et al. Among authors: yalcin s. Anticancer Drugs. 2019 Mar;30(3):289-294. doi: 10.1097/CAD.0000000000000728. Anticancer Drugs. 2019. PMID: 30640791

9

Analysis of Fusobacterium nucleatum and Streptococcus gallolyticus in saliva of colorectal cancer patients.

Guven DC, Dizdar O, Alp A, Akdoğan Kittana FN, Karakoc D, Hamaloglu E, Lacin S, Karakas Y, Kilickap S, Hayran M, Yalcin S. Guven DC, et al. Among authors: yalcin s. Biomark Med. 2019 Jun;13(9):725-735. doi: 10.2217/bmm-2019-0020. Epub 2019 Jun 3. Biomark Med. 2019. PMID: 31157977

10

COVID-19 pandemic: changes in cancer admissions.

Guven DC, Aktas BY, Aksun MS, Ucgul E, Sahin TK, Yildirim HC, Guner G, Kertmen N, Dizdar O, Kilickap S, Aksoy S, Yalcin S, Turker A, Uckun FM, Arik Z. Guven DC, et al. Among authors: yalcin s. BMJ Support Palliat Care. 2020 Jul 14:bmjspcare-2020-002468. doi: 10.1136/bmjspcare-2020-002468. Online ahead of print. BMJ Support Palliat Care. 2020. PMID: 32665259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,135 results

Search Page

Filters